Abstract

490 Long term survival and incidence of brain metastasis in HER2- positive (HER2+) metastatic breast cancer patients (MBC) treated with trastuzumab (T): an institutional based review

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract P1-02-09: Clinical significance of sequential measurements of ESR1 mutations in plasma cell-free DNA in estrogen receptor positive recurrent metastatic breast cancer patients
T Takeshita ... H Iwase
Cancer Research | VOL. 77
T Takeshita, et. al.T Takeshita ... H Iwase
14 Feb 2017
Abstract PO5-04-01: Inetetamab combined with sirolimus and chemotherapy in HER2 positive metastatic breast cancer patients with abnormal activation of Pi3k/Akt/mTOR pathway after trastuzumab treatment
Qiao Li ... Dan Lv
Cancer Research | VOL. 84
Qiao Li, et. al.Qiao Li ... Dan Lv
02 May 2024
Abstract P1-01-01: Circulating tumor cell number and CTC-endocrine therapy index predict clinical outcomes in ER positive metastatic breast cancer patients: Results of the COMETI Phase 2 trial
C Paoletti ... Pj Goodwin
Cancer Research | VOL. 77
C Paoletti, et. al.C Paoletti ... Pj Goodwin
14 Feb 2017
P2-12-05: Correlation between Quantitative HER2 Protein Expression and Risk of Brain Metastases in HER2−Positive Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy.
...
Cancer Research | VOL. 71
, et. al. ...
15 Dec 2011
View more papers

More From: EJC Supplements

Paper Title
Journal
Date
Author
Immunotherapies in ovarian cancer
Elena García-Martínez ... J Alejandro Pérez-Fidalgo
EJC Supplements | VOL. 15
Elena García-Martínez, et. al.Elena García-Martínez ... J Alejandro Pérez-Fidalgo
01 Aug 2020
Anti-angiogenic therapy for ovarian cancer
Yolanda García García ... Clara Martínez Vila
EJC Supplements | VOL. 15
Yolanda García García, et. al.Yolanda García García ... Clara Martínez Vila
01 Aug 2020
Editorial board
-
EJC Supplements | VOL. 13
--
01 Dec 2015
Biosimilars: Extrapolating the evidence. A roundtable discussion
Bradley J Monk ... George Somlo
EJC Supplements | VOL. 13
Bradley J Monk, et. al.Bradley J Monk ... George Somlo
01 Dec 2015
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.